Coronavirus in Pregnant Patients and their Clinical Outcomes – Results of a Case-Control Study

Main Article Content

Romir Kadriu
Ilir Demiri
Goran Dimitrov

Abstract

BACKGROUND: The outbreak of COVID-19, caused by the novel coronavirus SARS-CoV-2, has prompted extensive research efforts to understand its diverse clinical presentations and impacts on different patient populations. Among these populations, pregnant women have received considerable attention due to concerns about the potential consequences of COVID-19 during pregnancy.


AIM: The primary objective of this study is to determine whether pregnant patients with SARS-CoV-2 experience different outcomes than age-matched non-pregnant patients in terms of acute episode outcomes such as need for oxygen therapy and treatment outcome. A secondary objective of the study is to determine the presence of risk factors for the outcome of SARS-CoV-2 infection, such as the presence of comorbidities, but also the level of various laboratory markers during hospital stay, and their differences between cases and controls.


METHODS: Cases were defined as patients who had 1) a finding confirming their pregnancy (ultrasound finding) available in their documentation or electronic record, 2) a positive test for SARS-CoV-2, based on the PCR method, as well as 3) symptomatology from the upper respiratory system or systemic signs. As control patients, they were defined in the same way as the cases, but with the information that they are not pregnant. During the hospital stay, multiple laboratory measurements of peripheral blood parameters, including complete blood count (erythrocytes, leukocytes, platelets, and differential blood count), C-reactive protein, lactate dehydrogenase activity, and d -dimers. Statistical analysis was carried out using appropriate software (SPSS). Descriptive statistics, including means, standard deviations, and percentages, were used to summarize the characteristics of the study population.


RESULTS: Statistically significantly lower values ​​were found in pregnant women for oxygen saturation and the number of platelets, while a statistically significant increase was found in the number of leukocytes, D-dimers, urea and glucose. There are statistically significant differences analyzed by Chi-square test in the variables non-invasive ventilation, specific therapy for corona (remdesivir, tocilizumab, favipiravir), diabetes and other cause that may affect the outcome of SARS-CoV-2.


CONCLUSIONS: These findings indicate that pregnant women may have different clinical profiles when affected by COVID-19, emphasizing the importance of tailored health care strategies for this population.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Kadriu R, Demiri I, Dimitrov G. Coronavirus in Pregnant Patients and their Clinical Outcomes – Results of a Case-Control Study. Maced Med Electron J [Internet]. 2023 Nov. 18 [cited 2024 Jun. 25];3(1):1-6. Available from: https://www.id-press.eu/mmej/article/view/6107
Section
Clinical Medicine

References

Gomez-Ochoa S, Franco OH, Rojas LD, Raguindin PF, Roa-Diaz ZM, Wyssmann BM, et al. COVID-19 in Healthcare Workers : A Living Systematic Review and Meta-analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes. Am J Epidemiol [Internet]. 2021;190(1):161-75. Available from: https://pubmed.ncbi.nlm.nih.gov/32870978/

https://doi.org/10.1093/aje/kwaa191 DOI: https://doi.org/10.1093/aje/kwaa191

Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis [Internet]. 2021 Dec 1 [cited 2023 Nov 2];21(1). Available from: /pmc/articles/PMC8380115/

https://doi.org/10.1186/s12879-021-06536-3 DOI: https://doi.org/10.1186/s12879-021-06536-3

Choi JH, Choi SH, Yun KW. Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis. J Korean Med Sci [Internet]. 2022 [cited 2023 Nov 2];37(5). Available from: https://pubmed.ncbi.nlm.nih.gov/35132841/

https://doi.org/10.3346/jkms.2022.37.e35 DOI: https://doi.org/10.3346/jkms.2022.37.e35

Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ [Internet]. 2020 Sep 1 [cited 2023 Nov 2];370. Available from: https://pubmed.ncbi.nlm.nih.gov/32873575/

https://doi.org/10.1097/01.aoa.0000744128.44930.48 DOI: https://doi.org/10.1097/01.aoa.0000744128.44930.48

Smith ER, Oakley E, Grandner GW, Rukundo G, Farooq F, Ferguson K, et al. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis [Internet]. Vol. 228, American Journal of Obstetrics and Gynecology. Am J Obstet Gynecol; 2023 [cited 2023 Nov 2]. p. 161-77. Available from: https://pubmed.ncbi.nlm.nih.gov/36027953/

Conde-Agudelo A, Romero R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol [Internet]. 2022 Jan 1 [cited 2023 Nov 2];226(1):68. Available from: /pmc/articles/PMC8294655/

https://doi.org/10.1016/j.ajog.2021.07.009 DOI: https://doi.org/10.1016/j.ajog.2021.07.009

Di Toro F, Gjoka M, Di Lorenzo G, De Santo D, De Seta F, Maso G, et al. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Microbiol Infect [Internet]. 2021 Jan 1 [cited 2023 Nov 2];27(1):36-46. Available from: https://pubmed.ncbi.nlm.nih.gov/33148440/

https://doi.org/10.1016/j.cmi.2020.10.007 DOI: https://doi.org/10.1016/j.cmi.2020.10.007

Simbar M, Nazarpour S, Sheidaei A. Evaluation of pregnancy outcomes in mothers with COVID-19 infection: a systematic review and meta-analysis [Internet]. Vol. 43, Journal of Obstetrics and Gynaecology. J Obstet Gynaecol; 2023 [cited 2023 Nov 2]. Available from: https://pubmed.ncbi.nlm.nih.gov/36651606/

https://doi.org/10.1080/01443615.2022.2162867 DOI: https://doi.org/10.1080/01443615.2022.2162867

Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet [Internet]. 2020 Mar 7 [cited 2023 Nov 2];395(10226):809-15. Available from: https://pubmed.ncbi.nlm.nih.gov/32151335/

https://doi.org/10.1016/S0140-6736(20)30360-3 DOI: https://doi.org/10.1016/S0140-6736(20)30360-3

Al-kuraishy HM, Al-Gareeb AI, Albezrah NKA, Bahaa HA, El-Bouseary MM, Alexiou A, et al. Pregnancy and COVID-19: high or low risk of vertical transmission [Internet]. Vol. 23, Clinical and Experimental Medicine. Nature Publishing Group; 2023 [cited 2023 Nov 2]. p. 957-67. Available from: /pmc/articles/PMC9574177/

https://doi.org/10.1007/s10238-022-00907-z DOI: https://doi.org/10.1007/s10238-022-00907-z

Villar J, Soto Conti CP, Gunier RB, Ariff S, Craik R, Cavoretto PI, et al. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study. Lancet [Internet]. 2023 Feb 11 [cited 2023 Nov 2];401(10375):447-57. Available from: http://www.thelancet.com/article/S0140673622024679/fulltext

https://doi.org/10.1016/S0140-6736(22)02467-9 DOI: https://doi.org/10.1016/S0140-6736(22)02467-9

Stojanoska T, Cvetanovska M, Demiri I, Stevanovic M, Saveski V, Ridova N, et al. PULMONARY EMBOLISM: A COMPLICATION OF COVID -19 INFECTION IN POSTPARTUM - CASE REPORT. J Morphol Sci [Internet]. 2021 [cited 2023 Nov 2];4(3):126-30. Available from: https://repository.ukim.mk:443/handle/20.500.12188/16723

https://doi.org/10.55302/JMS2143126s DOI: https://doi.org/10.55302/JMS2143126s

Cvetanovska M, Demiri I, Grozdanovski K, Spasovska K, Daneva Markova A, Stojanoska T, et al. Covid-19 and pregnancy-our experiences. 2021 [cited 2023 Nov 2]; Available from: https://repository.ukim.mk:443/handle/20.500.12188/16724